A monthly review of the most important psychedelics research.
This month we’ve learned about sleep quality after MDMA, microdosing leaves creativity hanging, and an exciting Phase II study with nitrous oxide was published. The
Psychedelic research in May took another critical step forward. The publication of a large part of the phase III trial data from MAPS showed MDMA-assisted
Psychedelic research in April pitted psychedelics against SSRIs, gave mice a break from tripping, and identified new psychedelics. As we’re awaiting the full results of the MAPS Phase
Balazs Szigeti and colleagues ran the largest self-blinding experiment to date (191 participants) and found that the placebo and microdosing groups both experienced similar improvements
A review of the most important research into psychedelics published in February 2021.
A review of the most important research into psychedelics published in January 2021.